✦ LIBER ✦

Capecitabine ± lapatinib in advanced HER2 breast cancer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2096 ORAL Lapatinib (L) plus Capecitabin

✍ J. Crown; D. Cameron; A.M. Martin; B. Newstat; T. Pienkowski; A. Jagiello-Gruszf 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A phase two randomised trial of neratini

✍ Martin, Miguel; Bonneterre, Jacques; Geyer, Charles E.; Ito, Yoshinori; Ro, Jung 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 539 KB

Efficacy, safety, pharmacokinetics and b

✍ Iwata, Hiroji; Fujii, Hirofumi; Masuda, Norikazu; Mukai, Hirofumi; Nishimura, Yu 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 300 KB

4–47 Lapatinib plus Capecitabine for HER

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Lapatinib plus capecitabine promising fo

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Dual HER1/HER2 inhibitor lapatinib in ad

✍ Jame Abraham 📂 Article 📅 2007 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 127 KB